4 minute read
Aug. 26, 2022

Compound 3f: an Oral Factor XIa (FXIa) Inhibitor for Thromboembolic Diseases

compound 3f

oral Factor XIa inhibitor IV efficacy in rabbit AV shunt model from literature starting point and SBDD J. Med. Chem., July 21, 2022 Janssen Research & Development, L.L.C., Spring House, PA

drughunter.com
Drug Hunter Team
Loading...

twitterlinkedinemail

Other molecules you may be interested in